A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
A ttendants at the San Antonio Breast Cancer Symposium in December were treated to a remarkable coincidence: two scientists, each unaware of the other's research, reporting the same findings in backto-back presentations. Rowan Chlebowski, M.D., Ph.D., from the University of California, Los Angeles, and Gad Rennert, M.D., Ph.D., from the Technion-Israel Institute of Technology, in Haifa, both described evidence to suggest that bisphosphonate treatment for bone loss protects against breast cancerdoi:10.1093/jnci/djq114 pmid:20339136 fatcat:gooparrjpzav3cwt4bgcbj3wiq